சீனா உயிரியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from சீனா உயிரியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In சீனா உயிரியல் Today - Breaking & Trending Today
[CMG중국통신] 中 코로나19 백신 누적 6억 3900만 도스 접종 joins.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from joins.com Daily Mail and Mail on Sunday newspapers.
Centurium-led consortium completes $4.76b take-private deal of China Biologic April 22, 2021 Nasdaq-listed biopharmaceutical firm China Biologic Products Holdings suspended the trading of its shares on Wall Street on Wednesday, after the completion of a take-private deal sponsored by a Chinese buyout group that valued the firm at about $4.76 billion. The consortium is led by entities affiliated with Centurium Capital, a private equity (PE) firm founded by former Warburg Pincus partner David Li. Other investors in the consortium include Chinese PE company CITIC Capital; Asia-focused Hillhouse Capital; and V-Sciences Investments, a subsidiary of Singapore’s Temasek Holdings, among others. China Biologic signed the deal in November 2020, in which the investors had agreed to pay $120 per share in cash to privatise the firm through its merger with CBPO Group Limited. China Biologic will cease to be a publicly-traded company as a result of the deal. ....
China Biologic Announces Completion of Going Private Transaction News provided by Share this article Share this article BEIJING, April 20, 2021 /PRNewswire/ China Biologic Products Holdings, Inc. (NASDAQ: CBPO, China Biologic or the Company ), a leading fully integrated plasma-based biopharmaceutical company in China, today announced the completion of its merger (the Merger ) with CBPO Group Limited ( Merger Sub ), a wholly owned subsidiary of CBPO Holdings Limited ( Parent ), pursuant to the previously announced agreement and plan of merger, dated as of November 19, 2020 (the Merger Agreement ) among the Company, Parent and Merger Sub. As a result of the Merger, the Company became a wholly owned subsidiary of Parent and will cease to be a publicly traded company. ....
China Biologic Announces Shareholders Approval of Merger Agreement News provided by Share this article Share this article BEIJING, March 1, 2021 /PRNewswire/ China Biologic Products Holdings, Inc. (NASDAQ: CBPO, China Biologic or the Company ), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that, at an extraordinary general meeting (the EGM ) held today, the Company s shareholders voted in favor of the proposal to authorize and approve the previously announced agreement and plan of merger, dated as of November 19, 2020 (the Merger Agreement ), among the Company, CBPO Holdings Limited ( Parent ) and CBPO Group Limited ( Merger Sub ), pursuant to which, Merger Sub will be merged with and into the Company with the Company continuing as the surviving company and becoming a wholly owned subsidiary of Parent (the Merger ), the plan of merger (the Plan of Merger ) required to be filed with the Registrar of Compani ....
중국 외교부, 각 측과 함께 글로벌 생물 다양성 보호 대계를 논의 할것이라고 표시-CRI korean.cri.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from korean.cri.cn Daily Mail and Mail on Sunday newspapers.